The clinical research industry has experienced a seismic shift over the past few years, from the pandemic to decentralised trials to technological innovations.
Women's health pharma Exeltis USA has been reprimanded by the FDA for making a Facebook post that promoted its birth control product Slynd, overstating its efficacy and fa
